Loading…

Assessing Regurgitation Severity, Adverse Remodeling, and Fibrosis with CMR in Primary Mitral Regurgitation

Purpose of Review This review offers an evidence-based analysis of established and emerging cardiovascular magnetic resonance (CMR) techniques used to assess the severity of primary mitral regurgitation (MR), identify adverse cardiac remodeling and its prognostic effect. The aim is to provide differ...

Full description

Saved in:
Bibliographic Details
Published in:Current cardiology reports 2024-07, Vol.26 (7), p.705-715
Main Authors: Darwish, Amr, Bersali, Akila, Saeed, Mujtaba, Dhore, Aneesh, Maragiannis, Dimitrios, El-Tallawi, K. Carlos, Shah, Dipan J.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c298t-1482bb495abcf972212ac95e5ddb0aa90b39377789c978c5b7ee73239e6099ab3
container_end_page 715
container_issue 7
container_start_page 705
container_title Current cardiology reports
container_volume 26
creator Darwish, Amr
Bersali, Akila
Saeed, Mujtaba
Dhore, Aneesh
Maragiannis, Dimitrios
El-Tallawi, K. Carlos
Shah, Dipan J.
description Purpose of Review This review offers an evidence-based analysis of established and emerging cardiovascular magnetic resonance (CMR) techniques used to assess the severity of primary mitral regurgitation (MR), identify adverse cardiac remodeling and its prognostic effect. The aim is to provide different insights regarding clinical decision-making and enhance the clinical outcomes of patients with MR. Recent Findings Cardiac remodeling and myocardial replacement fibrosis are observed frequently in the presence of substantial LV volume overload, particularly in cases with severe primary MR. CMR serves as a useful diagnostic imaging modality in assessing mitral regurgitation severity, early detection of cardiac remodeling, myocardial dysfunction, and myocardial fibrosis, enabling timely intervention before irreversible damage ensues. Summary Incorporating myocardial remodeling in terms of left ventricular (LV) dilatation and myocardial fibrosis with quantitative MR severity assessment by CMR may assist in defining optimal timing of intervention.
doi_str_mv 10.1007/s11886-024-02069-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3055453272</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3055453272</sourcerecordid><originalsourceid>FETCH-LOGICAL-c298t-1482bb495abcf972212ac95e5ddb0aa90b39377789c978c5b7ee73239e6099ab3</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoOl5ewIVk6WKquTSTZDkM3kBRRl2HpD1To512TFpl3t5oVXDjIuTA-c4P_4fQISUnlBB5GilVapIRlqdHJjpTG2hEBc8zTiXZ_JwZz7hUbAftxvhMEkVkvo12uJK54kyP0Ms0RojRNxWeQ9WHyne2822D7-ENgu_WYzwt0xQh7ZdtCXVCx9g2JT73LrTRR_zuuyc8u5lj3-C74Jc2rPGN74Kt_2buo62FrSMcfP976PH87GF2mV3fXlzNptdZwbTqMpor5lyuhXXFQkvGKLOFFiDK0hFrNXFccyml0oWWqhBOAkjOuIYJ0do6voeOh9xVaF97iJ1Z-lhAXdsG2j4aToTIBWeSJZQNaJGqxAALsxoKGErMp2QzSDZJsvmSbFQ6OvrO790Syt-TH6sJ4AMQ06qpIJjntg9N6vxf7Ac-p4hY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3055453272</pqid></control><display><type>article</type><title>Assessing Regurgitation Severity, Adverse Remodeling, and Fibrosis with CMR in Primary Mitral Regurgitation</title><source>Springer Link</source><creator>Darwish, Amr ; Bersali, Akila ; Saeed, Mujtaba ; Dhore, Aneesh ; Maragiannis, Dimitrios ; El-Tallawi, K. Carlos ; Shah, Dipan J.</creator><creatorcontrib>Darwish, Amr ; Bersali, Akila ; Saeed, Mujtaba ; Dhore, Aneesh ; Maragiannis, Dimitrios ; El-Tallawi, K. Carlos ; Shah, Dipan J.</creatorcontrib><description>Purpose of Review This review offers an evidence-based analysis of established and emerging cardiovascular magnetic resonance (CMR) techniques used to assess the severity of primary mitral regurgitation (MR), identify adverse cardiac remodeling and its prognostic effect. The aim is to provide different insights regarding clinical decision-making and enhance the clinical outcomes of patients with MR. Recent Findings Cardiac remodeling and myocardial replacement fibrosis are observed frequently in the presence of substantial LV volume overload, particularly in cases with severe primary MR. CMR serves as a useful diagnostic imaging modality in assessing mitral regurgitation severity, early detection of cardiac remodeling, myocardial dysfunction, and myocardial fibrosis, enabling timely intervention before irreversible damage ensues. Summary Incorporating myocardial remodeling in terms of left ventricular (LV) dilatation and myocardial fibrosis with quantitative MR severity assessment by CMR may assist in defining optimal timing of intervention.</description><identifier>ISSN: 1523-3782</identifier><identifier>ISSN: 1534-3170</identifier><identifier>EISSN: 1534-3170</identifier><identifier>DOI: 10.1007/s11886-024-02069-8</identifier><identifier>PMID: 38748329</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Cardiac PET ; Cardiology ; Fibrosis ; Humans ; Magnetic Resonance Imaging, Cine - methods ; Medicine ; Medicine &amp; Public Health ; Mitral Valve - diagnostic imaging ; Mitral Valve - pathology ; Mitral Valve - physiopathology ; Mitral Valve Insufficiency - diagnostic imaging ; Mitral Valve Insufficiency - physiopathology ; MRI ; MRI (P Cremer ; Myocardium - pathology ; Prognosis ; Section Editor ; Severity of Illness Index ; Topical Collection on Cardiac PET ; Ventricular Remodeling</subject><ispartof>Current cardiology reports, 2024-07, Vol.26 (7), p.705-715</ispartof><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c298t-1482bb495abcf972212ac95e5ddb0aa90b39377789c978c5b7ee73239e6099ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38748329$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Darwish, Amr</creatorcontrib><creatorcontrib>Bersali, Akila</creatorcontrib><creatorcontrib>Saeed, Mujtaba</creatorcontrib><creatorcontrib>Dhore, Aneesh</creatorcontrib><creatorcontrib>Maragiannis, Dimitrios</creatorcontrib><creatorcontrib>El-Tallawi, K. Carlos</creatorcontrib><creatorcontrib>Shah, Dipan J.</creatorcontrib><title>Assessing Regurgitation Severity, Adverse Remodeling, and Fibrosis with CMR in Primary Mitral Regurgitation</title><title>Current cardiology reports</title><addtitle>Curr Cardiol Rep</addtitle><addtitle>Curr Cardiol Rep</addtitle><description>Purpose of Review This review offers an evidence-based analysis of established and emerging cardiovascular magnetic resonance (CMR) techniques used to assess the severity of primary mitral regurgitation (MR), identify adverse cardiac remodeling and its prognostic effect. The aim is to provide different insights regarding clinical decision-making and enhance the clinical outcomes of patients with MR. Recent Findings Cardiac remodeling and myocardial replacement fibrosis are observed frequently in the presence of substantial LV volume overload, particularly in cases with severe primary MR. CMR serves as a useful diagnostic imaging modality in assessing mitral regurgitation severity, early detection of cardiac remodeling, myocardial dysfunction, and myocardial fibrosis, enabling timely intervention before irreversible damage ensues. Summary Incorporating myocardial remodeling in terms of left ventricular (LV) dilatation and myocardial fibrosis with quantitative MR severity assessment by CMR may assist in defining optimal timing of intervention.</description><subject>Cardiac PET</subject><subject>Cardiology</subject><subject>Fibrosis</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging, Cine - methods</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mitral Valve - diagnostic imaging</subject><subject>Mitral Valve - pathology</subject><subject>Mitral Valve - physiopathology</subject><subject>Mitral Valve Insufficiency - diagnostic imaging</subject><subject>Mitral Valve Insufficiency - physiopathology</subject><subject>MRI</subject><subject>MRI (P Cremer</subject><subject>Myocardium - pathology</subject><subject>Prognosis</subject><subject>Section Editor</subject><subject>Severity of Illness Index</subject><subject>Topical Collection on Cardiac PET</subject><subject>Ventricular Remodeling</subject><issn>1523-3782</issn><issn>1534-3170</issn><issn>1534-3170</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMoOl5ewIVk6WKquTSTZDkM3kBRRl2HpD1To512TFpl3t5oVXDjIuTA-c4P_4fQISUnlBB5GilVapIRlqdHJjpTG2hEBc8zTiXZ_JwZz7hUbAftxvhMEkVkvo12uJK54kyP0Ms0RojRNxWeQ9WHyne2822D7-ENgu_WYzwt0xQh7ZdtCXVCx9g2JT73LrTRR_zuuyc8u5lj3-C74Jc2rPGN74Kt_2buo62FrSMcfP976PH87GF2mV3fXlzNptdZwbTqMpor5lyuhXXFQkvGKLOFFiDK0hFrNXFccyml0oWWqhBOAkjOuIYJ0do6voeOh9xVaF97iJ1Z-lhAXdsG2j4aToTIBWeSJZQNaJGqxAALsxoKGErMp2QzSDZJsvmSbFQ6OvrO790Syt-TH6sJ4AMQ06qpIJjntg9N6vxf7Ac-p4hY</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Darwish, Amr</creator><creator>Bersali, Akila</creator><creator>Saeed, Mujtaba</creator><creator>Dhore, Aneesh</creator><creator>Maragiannis, Dimitrios</creator><creator>El-Tallawi, K. Carlos</creator><creator>Shah, Dipan J.</creator><general>Springer US</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240701</creationdate><title>Assessing Regurgitation Severity, Adverse Remodeling, and Fibrosis with CMR in Primary Mitral Regurgitation</title><author>Darwish, Amr ; Bersali, Akila ; Saeed, Mujtaba ; Dhore, Aneesh ; Maragiannis, Dimitrios ; El-Tallawi, K. Carlos ; Shah, Dipan J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c298t-1482bb495abcf972212ac95e5ddb0aa90b39377789c978c5b7ee73239e6099ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cardiac PET</topic><topic>Cardiology</topic><topic>Fibrosis</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging, Cine - methods</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mitral Valve - diagnostic imaging</topic><topic>Mitral Valve - pathology</topic><topic>Mitral Valve - physiopathology</topic><topic>Mitral Valve Insufficiency - diagnostic imaging</topic><topic>Mitral Valve Insufficiency - physiopathology</topic><topic>MRI</topic><topic>MRI (P Cremer</topic><topic>Myocardium - pathology</topic><topic>Prognosis</topic><topic>Section Editor</topic><topic>Severity of Illness Index</topic><topic>Topical Collection on Cardiac PET</topic><topic>Ventricular Remodeling</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Darwish, Amr</creatorcontrib><creatorcontrib>Bersali, Akila</creatorcontrib><creatorcontrib>Saeed, Mujtaba</creatorcontrib><creatorcontrib>Dhore, Aneesh</creatorcontrib><creatorcontrib>Maragiannis, Dimitrios</creatorcontrib><creatorcontrib>El-Tallawi, K. Carlos</creatorcontrib><creatorcontrib>Shah, Dipan J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current cardiology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Darwish, Amr</au><au>Bersali, Akila</au><au>Saeed, Mujtaba</au><au>Dhore, Aneesh</au><au>Maragiannis, Dimitrios</au><au>El-Tallawi, K. Carlos</au><au>Shah, Dipan J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing Regurgitation Severity, Adverse Remodeling, and Fibrosis with CMR in Primary Mitral Regurgitation</atitle><jtitle>Current cardiology reports</jtitle><stitle>Curr Cardiol Rep</stitle><addtitle>Curr Cardiol Rep</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>26</volume><issue>7</issue><spage>705</spage><epage>715</epage><pages>705-715</pages><issn>1523-3782</issn><issn>1534-3170</issn><eissn>1534-3170</eissn><abstract>Purpose of Review This review offers an evidence-based analysis of established and emerging cardiovascular magnetic resonance (CMR) techniques used to assess the severity of primary mitral regurgitation (MR), identify adverse cardiac remodeling and its prognostic effect. The aim is to provide different insights regarding clinical decision-making and enhance the clinical outcomes of patients with MR. Recent Findings Cardiac remodeling and myocardial replacement fibrosis are observed frequently in the presence of substantial LV volume overload, particularly in cases with severe primary MR. CMR serves as a useful diagnostic imaging modality in assessing mitral regurgitation severity, early detection of cardiac remodeling, myocardial dysfunction, and myocardial fibrosis, enabling timely intervention before irreversible damage ensues. Summary Incorporating myocardial remodeling in terms of left ventricular (LV) dilatation and myocardial fibrosis with quantitative MR severity assessment by CMR may assist in defining optimal timing of intervention.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>38748329</pmid><doi>10.1007/s11886-024-02069-8</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1523-3782
ispartof Current cardiology reports, 2024-07, Vol.26 (7), p.705-715
issn 1523-3782
1534-3170
1534-3170
language eng
recordid cdi_proquest_miscellaneous_3055453272
source Springer Link
subjects Cardiac PET
Cardiology
Fibrosis
Humans
Magnetic Resonance Imaging, Cine - methods
Medicine
Medicine & Public Health
Mitral Valve - diagnostic imaging
Mitral Valve - pathology
Mitral Valve - physiopathology
Mitral Valve Insufficiency - diagnostic imaging
Mitral Valve Insufficiency - physiopathology
MRI
MRI (P Cremer
Myocardium - pathology
Prognosis
Section Editor
Severity of Illness Index
Topical Collection on Cardiac PET
Ventricular Remodeling
title Assessing Regurgitation Severity, Adverse Remodeling, and Fibrosis with CMR in Primary Mitral Regurgitation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A56%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20Regurgitation%20Severity,%20Adverse%20Remodeling,%20and%20Fibrosis%20with%20CMR%20in%20Primary%20Mitral%20Regurgitation&rft.jtitle=Current%20cardiology%20reports&rft.au=Darwish,%20Amr&rft.date=2024-07-01&rft.volume=26&rft.issue=7&rft.spage=705&rft.epage=715&rft.pages=705-715&rft.issn=1523-3782&rft.eissn=1534-3170&rft_id=info:doi/10.1007/s11886-024-02069-8&rft_dat=%3Cproquest_cross%3E3055453272%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c298t-1482bb495abcf972212ac95e5ddb0aa90b39377789c978c5b7ee73239e6099ab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3055453272&rft_id=info:pmid/38748329&rfr_iscdi=true